Funding Update

UFHCC & Extramural Opportunities

UFHCC Opportunities

UFHCC Bridge Grant Program

The UFHCC Bridge Grant Program is designed to support promising new research or competitive renewals that have nearly missed funding pay lines. The research must have strong cancer relevance; clinical, basic and population research grants are all acceptable.

For NCI and other cancer-focused NIH proposals, applications that have been scored or ranked within 5 percent of the institute’s published funding pay line will receive automatic bridge funding from the cancer center. Full-time UFHCC faculty members in Gainesville may apply. Newly recruited Assistant Professors are eligible to apply, whereas newly recruited senior faculty with start-up packages from the cancer center are not eligible.

AWARD AMOUNT & DURATION:

The maximum award for these grants is $75,000 direct cost for R01s and $50,000 for R21s. No IDC is allowed.
The award is for a period of one year and all funds are expected to be expended during that term.

Applications will be accepted on a rolling basis. Applicants should submit their full Federal proposal with a screenshot of their score/percentile to ResearchAdmin@cancer.ufl.edu. LEARN MORE.

Extramural Opportunities

The following is a list of new cancer-focused extramural funding opportunities. To stay updated throughout the month, please visit our website.

National Institutes of Health

Pediatric Immunotherapy Discovery and Development Network (PI-DDN) (U01) (U54) – LOI due date: 11/17/2017 Application due date: 12/19/17

Collaborative Minority Health and Health Disparities Research with Tribal Epidemiology Centers (R01 Clinical Trial Not Allowed) (R21 Clinical Trial Not Allowed) – Application due date: 12/4/17

Approaches to Identify and Care for Individuals with Inherited Cancer Syndromes (U01) – LOI due date: 12/9/17 Application due date: 1/9/18

Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional) LOI due date: 12/11/17 Application due date: 1/26/18

Immuno-Oncology Translation Network (IOTN): Cancer Immunotherapy Research Projects (U01) – LOI due date: 12/16/17 Application due date: 1/16/18

Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (U01) – LOI due date: 12/16/17 Application due date: 1/16/18

Immuno-Oncology Translation Network (IOTN): Data Management and Resource-Sharing Center (DMRC) (U24) – LOI due date: 12/16/17 Application due date: 1/16/18

Immuno-Oncology Translation Network (IOTN): Cellular Immunotherapy Data Resource (CIDR) (U24) – LOI due date: 12/16/17 Application due date: 1/16/18

Research Centers for Improving Management of Symptoms During and Following Cancer Treatment (UM1) – LOI due date: 12/17/17 Application due date: 1/17/18

National Cancer Institute Program Project Applications (P01 Clinical Trial Optional) – LOI due date: 12/26/17 Application due date: 1/25/18

NCI Research Specialist (Core-based Scientist) Award (R50) – LOI due date: 12/17/17 Application due date: 1/17/18

NCI Research Specialist (Laboratory-based Scientist) Award (R50) – LOI due date: 12/17/17 Application due date: 1/17/18

Coordinating Center for Research Centers for Improving Management of Symptoms During and Following Cancer Treatment (U24) – LOI due date: 12/17/17 Application due date: 1/17/18

“High” or “Medium” Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers
(R01) (R21) – Application due date: 1/7/2018

The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) – LOI due date: 1/8/18

Center of Excellence for Research on Complementary and Integrative Health (P01 Clinical Trial Optional) – Application due date: 1/17/18

Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities (P20) – LOI due date: 12/18/17 Application due date: 1/18/18

Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects
(R01 Clinical Trial Not Allowed) (R21 Clinical Trial Not Allowed)

Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Optional) – Application due date: 2/5/18

Addressing Health Disparities through Effective Interventions among Immigrant Populations (R01 Clinical Trial Optional) – Application due date: 2/5/18

Academic-Industrial Partnerships to Translate and Validate in vivo Cancer Imaging Systems (R01 Clinical Trial Optional) – Application due date: 2/5/18

Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R01 Clinical Trial Optional) (R21 Clinical Trial Optional) – Application due date: 2/5/18

Palliative Care Needs of Individuals with Rare Advanced Diseases and Their Family Caregivers (R01 Clinical Trial Optional) (R21 Clinical Trial Optional) – Application due date: 2/5/18

Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01 Clinical Trial Optional) (R21 Clinical Trial Optional) – Application due date: 2/5/18

Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R01 Clinical Trial Optional) (R21 Clinical Trial Optional) – Application due date: 2/5/18

The Health of Sexual and Gender Minority (SGM) Populations (R01 Clinical Trial Optional) (R03 Clinical Trial Optional) (R21 Clinical Trial Optional) – Application due date: 2/5/18

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed) – LOI due date: 1/14/17 Application due date: 2/14/18

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3) Clinical Trials Not Allowed – LOI due date: 1/14/17 Application due date: 2/14/18

Research on the Mechanisms and/or Behavioral Outcomes of Multisensory Processing (R01) – Application due date: 2/5/18

Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control (R21 Clinical Trial Optional) Application due date: 2/16/18

Research on the Health of Transgender and Gender Nonconforming Populations
(R01) (R21) – Application due date: 2/18/18

Short-term Mentored Career Enhancement Awards for Mid-Career Investigators to Integrate Basic Behavioral and Social Sciences (K18 Clinical Trial Required) – Application due date: 3/6/18

American Lung Association

Biomedical Research Grant – Application due date: 12/15/17

Dalsemer Research Grant – Application due date: 12/15/17

Clinical Patient Care Research Grant – Application due date: 12/21/17

Social-Behavioral Research Grant – Application due date: 12/21/17

Lung Health Dissertation Grant – Application due date: 12/21/17

Senior Research Training Fellowship – Application due date: 12/21/17

Burroughs Wellcome Fund

Postdoctoral Enrichment Program – Application due date: 1/16/18

Department of Defense